Results 281 to 289 of about 38,144 (289)

Opioid receptors: drivers to addiction?

Nature Reviews Neuroscience, 2018
Emmanuel Darcq, Brigitte Kieffer
exaly  

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

Lancet, The, 2019
Louisa J Degenhardt, Jason Grebely, jack Stone   +2 more
exaly  

Risk of mortality reduced during opioid agonist treatment

Reactions Weekly, 2020
openaire   +1 more source

NEW GUIDANCE ISSUED FOR OPIOID PAIN MEDICATION

Ca-A Cancer Journal for Clinicians, 2004
exaly  

Mortality risk: sedative drugs and opioid agonist treatment

Reactions Weekly, 2019
openaire   +1 more source

Chapter 50. Opioid-Related Disorders: Agonist Maintenance Treatment

2014
Richard S. Schottenfeld, Carla Marienfeld   +1 more
openaire   +1 more source

Opioid Agonist Treatment Modifications During COVID‐19 Pandemic

Drug and Alcohol Dependence
Beth Sproule, Jessica Stovel, Julia Saragosa, Helen Huynh, Francesca Di Paola, Bruna Brands, Maria Zhang   +6 more
openaire   +1 more source

Systematic Review: adverse effects in opioid agonist treatments

openaire   +1 more source